Companies /Healthcare

Bristol-Myers Squibb Company

NYSE: BMY Drug Manufacturers - General
$59.12
▼ $0.46 (−0.77%) today
Markets closed · 12:21am ET

BMY Coverage Page 36

10:01am ET
Health and Healthcare

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma.  The approval is a win for Bristol-Myers Squibb Company…

BMY
Jon C. Ogg